Showing results (211-220 of 322) with videos related to
Sort By:
Pageof 33
Cardiovascular Therapeutics|August 18, 2015
The Effect of a Cardiovascular Polypill Strategy on Pill BurdenMichael Truelove, Anushka Patel, Severine Bompoint, et al.American Heart Journal|August 2, 2024
deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trialAbdul Salam, Mahmoud U Sani, Okechukwu S Ogah, et al.JACC. Advances|June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of HypertensionNelson Wang, Phidias Rueter, Abdul Salam, et al.Drug and Alcohol Dependence|May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international surveyDilara Bahceci, Krista Siefried, Maureen Steele, et al.Journal of Human Hypertension|February 21, 2024
The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke StudyLiping Huang, Qiang Li, Jason Hy Wu, et al.JAMA|September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trialSimon Thom, Neil Poulter, Jane Field, et al.European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.Journal of Human Hypertension|July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost capsCatherine G Derington, Kyle Tong, Joshua A Jacobs, et al.Cerebrovascular Diseases (Basel, Switzerland)|May 25, 2026
Blood pressure lowering for the prevention of REcurrent stroke and Cardiovascular outcomes After acute intracerebral haemorrhage: protocol for an individual Participant data meta-analysis of randomised controlled trials (RECAP-ICH)M J Velasco, Yijie Gao, Shitian Li, et al.The Lancet. Rheumatology|January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS ProgramJingWei Li, Sunil V Badve, Zien Zhou, et al.Pageof 33